Literature DB >> 20017699

Stem cell paracrine actions and tissue regeneration.

Priya R Baraniak1, Todd C McDevitt.   

Abstract

Stem cells have emerged as a key element of regenerative medicine therapies due to their inherent ability to differentiate into a variety of cell phenotypes, thereby providing numerous potential cell therapies to treat an array of degenerative diseases and traumatic injuries. A recent paradigm shift has emerged suggesting that the beneficial effects of stem cells may not be restricted to cell restoration alone, but also due to their transient paracrine actions. Stem cells can secrete potent combinations of trophic factors that modulate the molecular composition of the environment to evoke responses from resident cells. Based on this new insight, current research directions include efforts to elucidate, augment and harness stem cell paracrine mechanisms for tissue regeneration. This article discusses the existing studies on stem/progenitor cell trophic factor production, implications for tissue regeneration and cancer therapies, and development of novel strategies to use stem cell paracrine delivery for regenerative medicine.

Entities:  

Mesh:

Year:  2010        PMID: 20017699      PMCID: PMC2833273          DOI: 10.2217/rme.09.74

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  229 in total

1.  Ex vivo gene therapy to produce bone using different cell types.

Authors:  D S Musgrave; P Bosch; J Y Lee; D Pelinkovic; S C Ghivizzani; J Whalen; C Niyibizi; J Huard
Journal:  Clin Orthop Relat Res       Date:  2000-09       Impact factor: 4.176

2.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes.

Authors:  Manuel Alvarez-Dolado; Ricardo Pardal; Jose M Garcia-Verdugo; John R Fike; Hyun O Lee; Klaus Pfeffer; Carlos Lois; Sean J Morrison; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2003-10-12       Impact factor: 49.962

3.  Vascular endothelial growth factor transgene expression in cell-transplanted hearts.

Authors:  Terrence M Yau; Guangming Li; Richard D Weisel; Adili Reheman; Zhi-Qiang Jia; Donald A G Mickle; Ren-Ke Li
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

4.  Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.

Authors:  Massimiliano Gnecchi; Luis G Melo
Journal:  Methods Mol Biol       Date:  2009

5.  Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis.

Authors:  Tianfu Li; Gaoying Ren; David L Kaplan; Detlev Boison
Journal:  Epilepsy Res       Date:  2009-02-12       Impact factor: 3.045

6.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

7.  Laser-induced thermal stress and the heat shock response in neural cells.

Authors:  Osa Emohare; Moustafa I Hafez; Ann Sandison; Richard R H Coombs; Ian D McCarthy
Journal:  Acta Orthop Scand       Date:  2004-10

8.  IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.

Authors:  Karen English; Frank P Barry; Ciara P Field-Corbett; Bernard P Mahon
Journal:  Immunol Lett       Date:  2007-04-26       Impact factor: 3.685

Review 9.  Cancer stem cells: a model in the making.

Authors:  Lauren L Campbell Marotta; Kornelia Polyak
Journal:  Curr Opin Genet Dev       Date:  2009-01-21       Impact factor: 5.578

10.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

View more
  282 in total

1.  Three-dimensional in vitro tri-culture platform to investigate effects of crosstalk between mesenchymal stem cells, osteoblasts, and adipocytes.

Authors:  Taymour M Hammoudi; Catherine A Rivet; Melissa L Kemp; Hang Lu; Johnna S Temenoff
Journal:  Tissue Eng Part A       Date:  2012-05-15       Impact factor: 3.845

2.  Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Cell Tissue Res       Date:  2011-08-11       Impact factor: 5.249

Review 3.  The Sertoli cell: one hundred fifty years of beauty and plasticity.

Authors:  L R França; R A Hess; J M Dufour; M C Hofmann; M D Griswold
Journal:  Andrology       Date:  2016-02-04       Impact factor: 3.842

4.  Anti-apoptotic Effects of Human Wharton's Jelly-derived Mesenchymal Stem Cells on Skeletal Muscle Cells Mediated via Secretion of XCL1.

Authors:  SooJin Kwon; Soo Mi Ki; Sang Eon Park; Min-Jeong Kim; Brian Hyung; Na Kyung Lee; Sangmi Shim; Byung-Ok Choi; Duk L Na; Ji Eun Lee; Jong Wook Chang
Journal:  Mol Ther       Date:  2016-06-23       Impact factor: 11.454

Review 5.  Concise review: immunological properties of ocular surface and importance of limbal stem cells for transplantation.

Authors:  Bakiah Shaharuddin; Sajjad Ahmad; Annette Meeson; Simi Ali
Journal:  Stem Cells Transl Med       Date:  2013-07-01       Impact factor: 6.940

6.  The Diverse Roles of Hydrogel Mechanics in Injectable Stem Cell Transplantation.

Authors:  Abbygail A Foster; Laura M Marquardt; Sarah C Heilshorn
Journal:  Curr Opin Chem Eng       Date:  2016-12-12       Impact factor: 5.163

7.  Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa.

Authors:  Gabriela Petrof; Su M Lwin; Magdalena Martinez-Queipo; Alya Abdul-Wahab; Simon Tso; Jemima E Mellerio; Ineke Slaper-Cortenbach; Jaap J Boelens; Jakub Tolar; Paul Veys; Mercy Ofuya; Janet L Peacock; Anna E Martinez; John A McGrath
Journal:  J Invest Dermatol       Date:  2015-04-23       Impact factor: 8.551

8.  Generation and characterization of transgenic mouse mesenchymal stem cell lines expressing hIGF-1 or hG-CSF.

Authors:  Gabrielle V M Gonçalves; Daniela N Silva; Rejane H Carvalho; Bruno S F Souza; Kátia Nunes da Silva; Juliana F Vasconcelos; Bruno D Paredes; Carolina K V Nonaka; Ricardo Ribeiro-Dos-Santos; Milena B P Soares
Journal:  Cytotechnology       Date:  2017-09-02       Impact factor: 2.058

9.  Engineered stem cell mimics to enhance stroke recovery.

Authors:  Paul M George; Byeongtaek Oh; Ruby Dewi; Thuy Hua; Lei Cai; Alexa Levinson; Xibin Liang; Brad A Krajina; Tonya M Bliss; Sarah C Heilshorn; Gary K Steinberg
Journal:  Biomaterials       Date:  2018-06-14       Impact factor: 12.479

Review 10.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.